Products for Research Use Only
RegisterLogin

(R) -STU104

CAT: 0804-HY-150612-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-150612-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
(R) -STU104 is a potent and orally active TAK1-MKK3 interaction inhibitor with IC50s of 0.58 μM and 4.0 μM for TNF-α and MKK3 phosphorylation. (R) -STU104 suppresses the TAK1/MKK3/p38/MnK1/MK2/elF4E signal pathways through binding with MKK3 and disrupting the TAK1 phosphorylating MKK3. (R) -STU104 can be used for researching ulcerative colitis[1].
CAS Number
2767124-77-4
UNSPSC
12352005
Target
P38 MAPK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/r-stu104.html
Purity
99.91
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1C[C@H](C2=CC=C(OC)C=C2)C3=C1C=C(OC)C=C3OC
Molecular Formula
C18H18O4
Molecular Weight
298.33
References & Citations
[1]Tang ML, et al. Discovery of First-in-Class TAK1-MKK3 Protein-Protein Interaction (PPI) Inhibitor (R) -STU104 for the Treatment of Ulcerative Colitis through Modulating TNF-α Production. J Med Chem. 2022 May 12;65 (9) :6690-6709.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-W998245(R, R, R) -AHPC (hydrochloride)
HY-W018061C-01(R, R) -Traxoprodil
HY-103451(R, R) -THC
HY-113834(R, R) -Ethambutol
HY-128888-01(R, R) -GSK321
HY-100443B-01(R, R) -PX20606
HY-B0761(R, R) -Glycopyrrolate
HY-59125-01(R, R) - (+) -Hydrobenzoin
HY-100741C-01(R, R) -S63845
HY-153321A-01(R, R) -Bexobrutideg

Alternative Products

CatalogName
BUP01416-01(R) -STU104
MBS5803381(R)-STU104
T207425-01(R) -STU104-d6

Popular Products